These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37886941)

  • 1. Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
    Nemteanu R; Clim A; Hincu CE; Gheorghe L; Ciortescu I; Plesa A
    Curr Issues Mol Biol; 2023 Sep; 45(10):7878-7890. PubMed ID: 37886941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future treatments for hepatitis delta virus infection.
    Asselah T; Loureiro D; Tout I; Castelnau C; Boyer N; Marcellin P; Mansouri A
    Liver Int; 2020 Feb; 40 Suppl 1():54-60. PubMed ID: 32077603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies for hepatitis delta virus infection.
    Loureiro D; Castelnau C; Tout I; Boyer N; Narguet S; Menasria Benazzouz S; Louis Z; Pons-Kerjean N; Giuly N; Marcellin P; Mansouri A; Asselah T
    Liver Int; 2021 Jun; 41 Suppl 1():30-37. PubMed ID: 34155804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Delta Hepatitis: Today and in the Future - A review.
    Bahcecioglu IH; Sahin A
    Infect Dis (Lond); 2017 Apr; 49(4):241-250. PubMed ID: 28092214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond bulevirtide: Alternative therapeutic options for the management of hepatitis delta virus.
    Asselah T
    J Viral Hepat; 2023 Apr; 30 Suppl 1():33-38. PubMed ID: 36529713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis in persons living with HIV in the post-COVID era.
    Soriano V; Moreno-Torres V; Mendoza C; Corral O; Barreiro P
    AIDS Rev; 2023; 25(1):1-13. PubMed ID: 36952663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D virus: Improving virological knowledge to develop new treatments.
    Khalfi P; Kennedy PT; Majzoub K; Asselah T
    Antiviral Res; 2023 Jan; 209():105461. PubMed ID: 36396025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent breakthroughs in the treatment of chronic hepatitis Delta.
    Brancaccio G; Gaeta L; Vitale A; Gaeta GB
    Infez Med; 2022; 30(2):204-210. PubMed ID: 35693059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022.
    Lampertico P; Degasperi E; Sandmann L; Wedemeyer H;
    JHEP Rep; 2023 Sep; 5(9):100818. PubMed ID: 37593170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on hepatitis D: From virology to new therapies.
    Mentha N; Clément S; Negro F; Alfaiate D
    J Adv Res; 2019 May; 17():3-15. PubMed ID: 31193285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.
    Urban S; Neumann-Haefelin C; Lampertico P
    Gut; 2021 Sep; 70(9):1782-1794. PubMed ID: 34103404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatitis delta and HIV infection.
    Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
    Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.
    Soriano V; Moreno-Torres V; Treviño A; Corral O; de Mendoza C
    Drug Des Devel Ther; 2023; 17():155-166. PubMed ID: 36712949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.
    Deterding K; Wedemeyer H
    AIDS Rev; 2019; 21(3):126-134. PubMed ID: 31532397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
    Zhang Z; Urban S
    J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bulevirtide for HBV and HDV infections.
    Yardeni D; Koh C
    Drugs Today (Barc); 2021 Jul; 57(7):433-448. PubMed ID: 34268531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Hepatitis D; at a Standstill?
    Rizzetto M
    Dig Dis; 2016; 34(4):303-7. PubMed ID: 27170382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulevirtide and emerging drugs for the treatment of hepatitis D.
    Xu HY; Yang JO; Chen PH; Han SB
    Expert Opin Biol Ther; 2023; 23(12):1245-1253. PubMed ID: 37853604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatitis D: an unmet medical need.
    Caviglia GP; Rizzetto M
    Clin Microbiol Infect; 2020 Jul; 26(7):824-827. PubMed ID: 32120043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.
    Wang W; Lempp FA; Schlund F; Walter L; Decker CC; Zhang Z; Ni Y; Urban S
    J Hepatol; 2021 Aug; 75(2):311-323. PubMed ID: 33845061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.